Inhibitors of mitogen-activated protein kinases protect axotomized developing neurons

Brain Research

Volumn 842, Issue 1, 1999, Pages 215-219

  Castagné, Vincent ^a   Clarke, Peter G H ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Axotomy; Mitogen activated protein kinase; Neuronal death; Redox status; Retina; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; GENE EXPRESSION REGULATION; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; SIGNAL TRANSDUCTION;

ANIMALS; AXOTOMY; CELL DEATH; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RETINAL GANGLION CELLS; SUPERIOR COLLICULUS;

EID: 0033581318     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01823-5     Document Type: Article

References (40)

1. Al-Abdulla N.A., Martin L.J. Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am. J. Pathol. 153:1998;447-456.
2. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
3. Atabay C., Cagnoli C.M., Kharlamov E., Ikonomovic M.D., Manev H. Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: protection with antioxidants and glutamate receptor antagonists. J. Neurosci. Res. 43:1996;465-475.
4. Burek M.J., Oppenheim R.W. Programmed cell death in the developing nervous system. Brain Pathol. 6:1996;427-446.
5. Castagné V., Clarke P.G.H. Axotomy-induced retinal ganglion cell death in development: its time course and its diminution by antioxidants. Proc. R. Soc. London. 263:1996;1193-1197.
6. Castagné V., Clarke P.G.H. Inhibition of glutathione synthesis can enhance cycloheximide-induced protection of developing neurons against axotomy. Dev. Brain Res. 102:1997;285-290.
7. Castagné V., Clarke P.G.H. Cooperation between glutathione depletion and protein synthesis inhibition against naturally occurring neuronal death. Neuroscience. 86:1998;895-902.
8. Castagné V., Lefèvre K., Natero R., Becker D.A., Clarke P.G.H. An optimal redox status for the survival of axotomized ganglion cells in the developing retina. Neuroscience. 93:1999;313-320.
9. Cimino F., Esposito F., Ammendola R., Russo T. Gene regulation by reactive oxygen species. Curr. Top. Cell. Regul. 35:1997;123-148.
10. Clarke P.G.H. Neuronal death during development in the isthmo-optic nucleus of the chick: sustaining role of afferents from the tectum. J. Comp. Neurol. 234:1985;365-379.
11. Clarke P.G.H. Neuronal death in the development of the vertebrate central nervous system. Semin. Neurosci. 6:1994;291-298.
12. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Letters. 364:1995;229-233.
13. Deshmukh M., Johnson E.M. Jr. Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol. 51:1997;897-906.
14. Dhanasekaran N., Reddy E.P. Signalling by dual specificity kinases. Oncogene. 17:1998;1447-1455.
15. Dugan L.L., Creedon D.J., Johnson E.M. Jr., Holtzman D.M. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4086-4091.
16. English J.D., Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272:1997;19103-19106.
17. Fanger G.R., Gerwins P., Widmann C., Jarpe M.B., Johnson G.L. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev. 7:1997;67-74.
18. Fukunaga K., Miyamoto E. Role of MAP kinase in neurons. Mol. Neurobiol. 16:1998;79-95.
19. Glicksman M.A., Chiu A.Y., Dionne C.A., Harty M., Kaneko M., Murakata C., Oppenheim R.W., Prevette D., Sengelaub D.R., Vaught J.L., Neff N.T. CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo. J. Neurobiol. 35:1998;361-370.
20. Greenlund L.J.S., Deckwerth T.L., Johnson E.M. Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
21. Gunn-Moore F.J., Tavaré J.M. Apoptosis of cerebellar granule cells induced by serum withdrawal, glutamate or β-amyloid, is independent of Jun kinase or p38 mitogen-activated protein kinase activation. Neurosci. Lett. 250:1998;53-56.
22. 2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:1996;4138-4142.
23. Heidenreich K.A., Kummer J.L. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J. Biol. Chem. 271:1996;9891-9894.
24. Herdegen T., Claret F.X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., Karin M. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18:1998;5124-5135.
25. Horstmann S., Kahle P.J., Borasio G.D. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 52:1998;483-490.
26. Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y., Nishida E. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272:1997;18518-18521.
27. Koliatsos V.E., Price D.L. Axotomy as an experimental model of neuronal injury and cell death. Brain Pathol. 6:1996;447-465.
28. Layer P.G., Vollmer G. Lucifer yellow stains displaced amacrine cells of the chicken retina during embryonic development. Neurosci. Lett. 31:1982;99-104.
29. Maas J.W. Jr., Horstmann S., Borasio G.D., Anneser J.M.H., Shooter E.M., Kahle P.J. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase mitogen-activated protein kinase inhibitors. J. Neurochem. 70:1998;1401-1410.
30. Murray B., Alessandrini A., Cole A.J., Yee A.G., Furshpan E.J. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11975-11980.
31. New L.G., Han J.H. The p38 MAP kinase pathway and its biological function. Trends Cardiovasc. Med. 8:1998;220-228.
32. Pettmann B., Henderson C.E. Neuronal cell death. Neuron. 20:1998;633-647.
33. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:1997.
34. Schulze-Osthoff K., Ferrari D., Riehemann K., Wesselborg S. Regulation of NF-kappaB activation by MAP kinase cascades. Immunobiology. 198:1997;35-49.
35. Villalba M., Bockaert J., Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17:1997;83-90.
36. Vincent S.R., Sebben M., Dumuis A., Bockaert J. Neurotransmitter regulation of MAP kinase signalling in striatal neurons in primary culture. Synapse. 29:1998;29-36.
37. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180.
38. Wilhelm D., Bender K., Knebel A., Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Molecular and Cellular Biology. 17:1997;4792-4800.
39. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
40. Xia Z., Dudek H., Miranti C.K., Greenberg M.E. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16:1996;5425-5436.